serine has been researched along with Adenoma Sebaceum in 10 studies
Serine: A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from GLYCINE or THREONINE. It is involved in the biosynthesis of PURINES; PYRIMIDINES; and other amino acids.
serine : An alpha-amino acid that is alanine substituted at position 3 by a hydroxy group.
Adenoma Sebaceum: Facial ANGIOFIBROMA in tuberous sclerosis
| Excerpt | Relevance | Reference |
|---|---|---|
| "Interestingly, in certain types of cancers (e." | 1.34 | Identification of S664 TSC2 phosphorylation as a marker for extracellular signal-regulated kinase mediated mTOR activation in tuberous sclerosis and human cancer. ( Bernardi, R; Bonner, P; Cordon-Cardo, C; Franz, DN; Ma, L; Pandolfi, PP; Teruya-Feldstein, J; Witte, D, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (70.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dutta, R | 1 |
| Sharma, MC | 1 |
| Suri, V | 1 |
| Sarkar, C | 1 |
| Garg, A | 1 |
| Suri, A | 1 |
| Kale, SS | 1 |
| Krishnamoorthy, J | 1 |
| Tenkerian, C | 1 |
| Gupta, J | 1 |
| Ghaddar, N | 1 |
| Wang, S | 1 |
| Darini, C | 1 |
| Staschke, KA | 1 |
| Ghosh, A | 1 |
| Gandin, V | 1 |
| Topisirovic, I | 1 |
| Kristof, AS | 1 |
| Hatzoglou, M | 1 |
| Simos, G | 1 |
| Koromilas, AE | 1 |
| Madigan, JP | 1 |
| Hou, F | 1 |
| Ye, L | 1 |
| Hu, J | 1 |
| Dong, A | 1 |
| Tempel, W | 1 |
| Yohe, ME | 1 |
| Randazzo, PA | 1 |
| Jenkins, LMM | 1 |
| Gottesman, MM | 1 |
| Tong, Y | 1 |
| Di Nardo, A | 1 |
| Kramvis, I | 1 |
| Cho, N | 1 |
| Sadowski, A | 1 |
| Meikle, L | 1 |
| Kwiatkowski, DJ | 1 |
| Sahin, M | 1 |
| Li, Y | 2 |
| Inoki, K | 2 |
| Yeung, R | 1 |
| Guan, KL | 2 |
| Vacratsis, P | 1 |
| Roux, PP | 1 |
| Ballif, BA | 1 |
| Anjum, R | 1 |
| Gygi, SP | 1 |
| Blenis, J | 1 |
| Ma, L | 2 |
| Chen, Z | 1 |
| Erdjument-Bromage, H | 1 |
| Tempst, P | 1 |
| Pandolfi, PP | 2 |
| Teruya-Feldstein, J | 1 |
| Bonner, P | 1 |
| Bernardi, R | 1 |
| Franz, DN | 1 |
| Witte, D | 1 |
| Cordon-Cardo, C | 1 |
| Pipo, JR | 1 |
| Yamamoto, T | 1 |
| Takeda, H | 1 |
| Maegawa, S | 1 |
| Nanba, E | 1 |
| Ninomiya, H | 1 |
| Ohno, K | 1 |
| Takeshita, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Pilot Study of Nintedanib for LymphAngioleioMyomatosis (LAM)[NCT03062943] | Phase 2 | 30 participants (Actual) | Interventional | 2016-12-06 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
10 other studies available for serine and Adenoma Sebaceum
| Article | Year |
|---|---|
TTF-1: A Well-Favored Addition to the Immunohistochemistry Armamentarium as a Diagnostic Marker of SEGA.
Topics: Astrocytoma; Brain Neoplasms; Child; Ependymoma; Glioblastoma; Humans; Immunohistochemistry; Neurocy | 2022 |
Downregulation of PERK activity and eIF2α serine 51 phosphorylation by mTOR complex 1 elicits pro-oxidant and pro-death effects in tuberous sclerosis-deficient cells.
Topics: Animals; Antioxidants; Cell Death; Cells, Cultured; Down-Regulation; eIF-2 Kinase; Eukaryotic Initia | 2018 |
The tuberous sclerosis complex subunit TBC1D7 is stabilized by Akt phosphorylation-mediated 14-3-3 binding.
Topics: 14-3-3 Proteins; beta-Transducin Repeat-Containing Proteins; Binding Sites; Carrier Proteins; Crysta | 2018 |
Tuberous sclerosis complex activity is required to control neuronal stress responses in an mTOR-dependent manner.
Topics: Animals; Animals, Newborn; Apoptosis; Carrier Proteins; Cells, Cultured; Child, Preschool; Dose-Resp | 2009 |
Regulation of TSC2 by 14-3-3 binding.
Topics: 14-3-3 Proteins; Adaptor Proteins, Signal Transducing; Animals; Binding Sites; Carrier Proteins; Cel | 2002 |
The p38 and MK2 kinase cascade phosphorylates tuberin, the tuberous sclerosis 2 gene product, and enhances its interaction with 14-3-3.
Topics: 14-3-3 Proteins; Amino Acid Sequence; Androstadienes; Anisomycin; Binding Sites; Culture Media, Seru | 2003 |
Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase.
Topics: Amino Acid Sequence; Animals; Cell Line; Enzyme Activation; Humans; MAP Kinase Signaling System; Mod | 2004 |
Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis.
Topics: Amino Acid Sequence; Animals; Cell Line; Extracellular Signal-Regulated MAP Kinases; Humans; In Vitr | 2005 |
Identification of S664 TSC2 phosphorylation as a marker for extracellular signal-regulated kinase mediated mTOR activation in tuberous sclerosis and human cancer.
Topics: Cells, Cultured; Extracellular Signal-Regulated MAP Kinases; Humans; Immunoblotting; Immunoprecipita | 2007 |
Two novel serine repeat length polymorphisms (1043insS and 1043insSS) at exon 23 of the TSC1 gene.
Topics: Exons; Genes, Tumor Suppressor; Humans; Mutagenesis, Insertional; Polymorphism, Genetic; Proteins; R | 2000 |